期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

奥曲肽对氧诱导视网膜新生血管抑制作用的研究 被引量：2

下载PDF
导出
摘要 视网膜新生血管是视网膜静脉阻塞、增殖型糖尿病视网膜病变、早产儿视网膜病变等疾病共有的病理改变．最终可导致视力减退甚至致盲。临床上对视网膜新生血管主要采用光凝治疗，但激光治疗只能延缓病变的进展，且手术可能损伤正常视网膜组织，导致中心视力损害。
作者 何华 李双农
机构地区 山西医科大学第一医院眼科
出处 《中国药物与临床》 CAS 2010年第3期295-297,共3页 Chinese Remedies & Clinics
关键词 视网膜新生血管 增殖型糖尿病视网膜病变 抑制作用 奥曲肽对 氧诱导 早产儿视网膜病变 视网膜静脉阻塞 视网膜组织
分类号 R774.1 [医药卫生—眼科] R735 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1Garcia de la Torre N,Wass JA,Turner HE. Antiangiogenic effects of somatostatin analogues. Clin Endocrinol(Oxt), 2002,57(4): 425-441.
  • 2Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmodynamic effects. Gut,1994,35(3 Suppl):1-4.
  • 3Mallet B,Vialettes B,Haroche S,et al. Stabilization of severe proliferative diabetic retinopathy by long term treatment with SMS201-995. Diabete Metab, 1992,18 (6) :438-444.
  • 4Grant MB, Mames RN, Fitzgerald C,et al. The efficacy of octreotide in the therapy of severe nonproliferation and early proliferation diabetic retinopathy. Diabetes Care,2000,23 (4):504- 509.
  • 5雷春涛,张学东,方静,李琦,周善璧.奥曲肽抑制小鼠视网膜新生血管形成的研究[J].眼科研究,2004,22(6):623-625. 被引量：11
  • 6Lamberts SWJ,Lely AJ,Herder WW. Octreotide. N Eng J Med, 1996,334(4):246-254.
  • 7Patel YC, Greenwood MT. Molecular biology of somatostatin receptou subtypes(Review). Metabolism, 1996,45( 1):31.
  • 8Barrie R, Woltering EA, Hajarizadeh H, et ah Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurely dependent. Surg Res, 1993,55:446-450.
  • 9Reisine T,Bell TI. Molecular biology of somatostatin receptors. Endocrinol Rev, 1995,16:427-442.
  • 10Smith LEH,Kopchick JJ,Chen W,et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Sience, 1997,276:1706-1709.

二级参考文献10

  • 1Nicosia RF,Nicosia SV,Smith MS.Vascular endothelial growth factor,platelet-derived growth factor,and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro[J].Am J Pathol,1994,145(5):1023-1029
  • 2Lamberts SWJ,Lely AJ,Herder WW.Octreotide[J].N Engl J Med,1996,334(4):246-254
  • 3Smith LEH,Wesolwski E,Mclellan A,et al.Oxygen-induced retinopathy in the mouse[J].Invest Ophthalmol Vis Sci,1994,35(1):101-111
  • 4Danesi R,Del-Tacca M.The effects of the somatostatin analog octreotide on angiogenesis in vitro[J].Metabolism,1996,45:S49-50
  • 5Lawnicka H,Stepien H,Wyczolkowska J,et al.Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture[J].Biochem Biophys Res Commun,2000,268(2)∶567-571
  • 6Murata T,Nakagawa K,Khalil A,et al.The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates[J].Lab Invest,1996,74(1):68-77
  • 7Tolentio MJ,Miller JW,Gragoudas ES,et al.Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate[J].Arch Ophthalmol,1996,114(8):971-977
  • 8Ozaki H,Seo MS,Ozaki K,et al.Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization[J].Am J Pathol,2000,156(2):697-707
  • 9Smith LE,Kopchick JJ,Chen W,et al.Essential role of growth hormone in ischemia-induced retinal neovascularization[J].Science,1997,276(13):1706-1709
  • 10Hellstrom A,Perruzzi C,Meihua J,et al.Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells:Direct correlation with clinical retinopathy of prematurity[J].Proc Natl Acad Sci,2001,98(10)∶5804-5808

共引文献10

同被引文献17

  • 1罗先琼,柳国胜,赖日权,聂川,吴坤河,田野,夏明翰,康举龄.血管内皮生长因子及其受体在早产儿视网膜病大鼠模型中的表达和作用[J].中华儿科杂志,2004,42(7):511-515. 被引量：16
  • 2雷春涛,张学东,方静,李琦,周善璧.奥曲肽抑制小鼠视网膜新生血管形成的研究[J].眼科研究,2004,22(6):623-625. 被引量：11
  • 3Nico sia RF,Nico sia SV,Smith MS. Vascular endothelial growth factor,plote-deried growth factor,and insuliulike growth factor comtte aortic ang iogenesis in vitro[J].American Journal of Pathology,1994,(05):1025-1029.
  • 4Peper J,Shweiki D,Itin A. Hypoxia2induced exp ression of vascular endothelial growth factor by retinal cells is a common factor in neovasculaizing ocular diseases[J].Laboratory Investigation,1995,(06):638-643.
  • 5Smith LEH,Kopchick JJ,Chen W. Essential role of growth hormone inischemiinducd retinal neovascularizatiOn[J].Science,1997.1706-1709.
  • 6Garcia dela Torre N,Wass JA,Turner HE. Antiangiogenic effects of somatostatin analogues[J].Clinical Endocrinology(Oxford),2002,(04):425-441.
  • 7Medina,D.L,Toro.M.J,Santisteban,P. Somatostatin interferes with thyroteopin-induced G1-S transition mediated bycAMP-dependent protein kinase and phosphatidylinositol3-kinase[J].Journal of Biological Chemistry,2000.15549-15556.
  • 8Ozako H,Seo MS,Ozaki K. Blockade of vascular endothelialgrowth factor receptor signaling is sufficient to completely prevent retinal neovascularization[J].Am J Pathlo,2000,(156):697-708.
  • 9Sm ith LE,shew W. regu le lion o f vascular ende thelial growth factor-depentent retinal nerovascularization by insulin-lite growth factor-1 recepotor[J].1999,(12):1390-1395.
  • 10Tatsuy a K,Daid V,K iyoshi S. Knockout of insulin and IGF -1 receptors on vascular endothelial cells protects against retinal neovascularization[J].Journal of Clinical Investigation,2003,(12):1835-1842.

引证文献2

二级引证文献7

中国药物与临床
2010年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部